H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs (original) (raw)

Accession codes

Primary accessions

Gene Expression Omnibus

References

1. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007).
   Article CAS Google Scholar
2. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676 (2006).
   Article CAS Google Scholar
3. Yamanaka, S. & Blau, H.M. Nuclear reprogramming to a pluripotent state by three approaches. Nature 465, 704–712 (2010).
   Article CAS Google Scholar
4. Hussein, S.M. et al. Copy number variation and selection during reprogramming to pluripotency. Nature 471, 58–62 (2011).
   Article CAS Google Scholar
5. Bar-Nur, O., Russ, H.A., Efrat, S. & Benvenisty, N. Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet β cells. Cell Stem Cell 9, 17–23 (2011).
   Article CAS Google Scholar
6. Plath, K. & Lowry, W.E. Progress in understanding reprogramming to the induced pluripotent state. Nat. Rev. Genet. 12, 253–265 (2011).
   Article CAS Google Scholar
7. Mikkelsen, T.S. et al. Dissecting direct reprogramming through integrative genomic analysis. Nature 454, 49–55 (2008).
   Article CAS Google Scholar
8. Sridharan, R. et al. Role of the murine reprogramming factors in the induction of pluripotency. Cell 136, 364–377 (2009).
   Article CAS Google Scholar
9. Ang, Y.S. et al. Wdr5 mediates self-renewal and reprogramming via the embryonic stem cell core transcriptional network. Cell 145, 183–197 (2011).
   Article CAS Google Scholar
10. Singhal, N. et al. Chromatin-remodeling components of the BAF complex facilitate reprogramming. Cell 141, 943–955 (2010).
    Article CAS Google Scholar
11. Onder, T.T. et al. Chromatin-modifying enzymes as modulators of reprogramming. Nature 483, 598–602 (2012).
    Article CAS Google Scholar
12. Li, R. et al. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell 7, 51–63 (2010).
    Article CAS Google Scholar
13. Samavarchi-Tehrani, P. et al. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell 7, 64–77 (2010).
    Article CAS Google Scholar
14. Silva, J. et al. Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol. 6, e253 (2008).
    Article Google Scholar
15. Mattout, A., Biran, A. & Meshorer, E. Global epigenetic changes during somatic cell reprogramming to iPS cells. J. Mol. Cell Biol. 3, 341–350 (2011).
    Article Google Scholar
16. Stadtfeld, M. et al. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 465, 175–181 (2010).
    Article CAS Google Scholar
17. Stadtfeld, M. et al. Ascorbic acid prevents loss of _Dlk1_-Dio3 imprinting and facilitates generation of all–iPS cell mice from terminally differentiated B cells. Nat. Genet. 44, 398–405 (2012).
    Article CAS Google Scholar
18. Chen, J. et al. Towards an optimized culture medium for the generation of mouse induced pluripotent stem cells. J. Biol. Chem. 285, 31066–31072 (2010).
    Article CAS Google Scholar
19. Esteban, M.A. et al. Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 6, 71–79 (2010).
    Article CAS Google Scholar
20. Wang, T. et al. The histone demethylases Jhdm1a/1b enhance somatic cell reprogramming in a vitamin-C–dependent manner. Cell Stem Cell 9, 575–587 (2011).
    Article CAS Google Scholar
21. Hanna, J.H., Saha, K. & Jaenisch, R. Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell 143, 508–525 (2010).
    Article CAS Google Scholar
22. Ichida, J.K. et al. A small-molecule inhibitor of Tgf-β signaling replaces Sox2 in reprogramming by inducing Nanog. Cell Stem Cell 5, 491–503 (2009).
    Article CAS Google Scholar
23. Herrera, B. & Inman, G.J. A rapid and sensitive bioassay for the simultaneous measurement of multiple bone morphogenetic proteins. Identification and quantification of BMP4, BMP6 and BMP9 in bovine and human serum. BMC Cell Biol. 10, 20 (2009).
    Article Google Scholar
24. David, L. et al. Bone morphogenetic protein-9 is a circulating vascular quiescence factor. Circ. Res. 102, 914–922 (2008).
    Article CAS Google Scholar
25. Wang, W. et al. Rapid and efficient reprogramming of somatic cells to induced pluripotent stem cells by retinoic acid receptor γ and liver receptor homolog 1. Proc. Natl. Acad. Sci. USA 108, 18283–18288 (2011).
    Article CAS Google Scholar
26. Feng, B. et al. Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb. Nat. Cell Biol. 11, 197–203 (2009).
    Article CAS Google Scholar
27. Fritsch, L. et al. A subset of the histone H3 lysine 9 methyltransferases Suv39h1, G9a, GLP, and SETDB1 participate in a multimeric complex. Mol. Cell 37, 46–56 (2010).
    Article CAS Google Scholar
28. Frontelo, P. et al. Suv39h histone methyltransferases interact with Smads and cooperate in BMP-induced repression. Oncogene 23, 5242–5251 (2004).
    Article CAS Google Scholar
29. Krishnan, S., Horowitz, S. & Trievel, R.C. Structure and function of histone H3 lysine 9 methyltransferases and demethylases. Chembiochem 12, 254–263 (2011).
    Article CAS Google Scholar
30. Loh, Y.H., Zhang, W., Chen, X., George, J. & Ng, H.H. Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem cells. Genes Dev. 21, 2545–2557 (2007).
    Article CAS Google Scholar
31. Hanna, J. et al. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 462, 595–601 (2009).
    Article CAS Google Scholar
32. Koche, R.P. et al. Reprogramming factor expression initiates widespread targeted chromatin remodeling. Cell Stem Cell 8, 96–105 (2011).
    Article CAS Google Scholar
33. Shi, Y. et al. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 3, 568–574 (2008).
    Article CAS Google Scholar
34. Lachner, M., O'Carroll, D., Rea, S., Mechtler, K. & Jenuwein, T. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410, 116–120 (2001).
    Article CAS Google Scholar
35. Lu, C. et al. IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature 483, 474–478 (2012).
    Article CAS Google Scholar
36. Oberdoerffer, P. & Sinclair, D.A. The role of nuclear architecture in genomic instability and ageing. Nat. Rev. Mol. Cell Biol. 8, 692–702 (2007).
    Article CAS Google Scholar
37. Chen, J. et al. BMPs functionally replace Klf4 and support efficient reprogramming of mouse fibroblasts by Oct4 alone. Cell Res. 21, 205–212 (2011).
    Article CAS Google Scholar
38. Childs, A.J. et al. BMP signaling in the human fetal ovary is developmentally regulated and promotes primordial germ cell apoptosis. Stem Cells 28, 1368–1378 (2010).
    Article CAS Google Scholar
39. Huang, W., Sherman, B.T. & Lempicki, R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44–57 (2009).
    Article CAS Google Scholar

Download references

Acknowledgements

We are grateful to X. Shu for careful reading and critical comments of the manuscript. We appreciate the contributions of J. Nie to microarray data analysis. We thank H. Zheng, X. Liu, J. Zhao, H. Wu, F. Li, D. Qin, R. Li, M. Esteban, G. Xu and B. Qin for constructive criticism. We also thank L. Zeng, G. Zhu, S. Sun, Y. Wu, K. Lai, H. Pang, H. Zhang, W. He, A. Jiang, T. Zhou, J. Li, S. Huang, J. Xu and D. Yang for technical assistance. We deeply appreciate the assistance of H. Song, K. Mo and S. Chu in blastocyst injection. This work is supported in part by the Strategic Priority Research Program of the Chinese Academy of Sciences (grants XDA01020401, XDA01020202 and XDA01020302), the National Basic Research Program of China (grants 2009CB941102, 2011CBA01106, 2011CB965204 and 2012CB966802), the National Natural Science Foundation of China (grants 31271357 and 91213304), the Ministry of Science and Technology International Technology Cooperation Program (grants 2010DFB30430 and 2012DFH30050), the National Science and Technology Major Special Project on Major New Drug Innovation (grant 2011ZX09102-010), the Bureau of Science and Technology of Guangzhou Municipality, China (grant 2010U1-E00521), the Guangdong Science and Technology Project (grants 2010A090603001 and 2011A08030002), Science and Technology Planning Project of Guangdong Province, China (grant 2011A060901019), the One Hundred Person Project of The Chinese Academy of Sciences to D.P., the Youth Innovation Promotion Association of the Chinese Academy of Sciences and the Pearl River Nova program (grant 2012J2200070). We wish to thank all members of our laboratories for their support.

Author information

Author notes

1. Jiekai Chen and He Liu: These authors contributed equally to this work.

Authors and Affiliations

1. Key Laboratory of Regenerative Biology, South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China
   Jiekai Chen, He Liu, Jing Liu, Jing Qi, Bei Wei, Jiaqi Yang, Hanquan Liang, You Chen, Jing Chen, Yaran Wu, Lin Guo, Jieying Zhu, Xiangjie Zhao, Tianran Peng, Yixin Zhang, Shen Chen, Xuejia Li, Dongwei Li, Tao Wang & Duanqing Pei
2. Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China
   Jiekai Chen, He Liu, Jing Liu, Jing Qi, Bei Wei, Jiaqi Yang, Hanquan Liang, You Chen, Jing Chen, Yaran Wu, Lin Guo, Jieying Zhu, Xiangjie Zhao, Tianran Peng, Yixin Zhang, Shen Chen, Xuejia Li, Dongwei Li, Tao Wang & Duanqing Pei

Authors

1. Jiekai Chen
   You can also search for this author inPubMed Google Scholar
2. He Liu
   You can also search for this author inPubMed Google Scholar
3. Jing Liu
   You can also search for this author inPubMed Google Scholar
4. Jing Qi
   You can also search for this author inPubMed Google Scholar
5. Bei Wei
   You can also search for this author inPubMed Google Scholar
6. Jiaqi Yang
   You can also search for this author inPubMed Google Scholar
7. Hanquan Liang
   You can also search for this author inPubMed Google Scholar
8. You Chen
   You can also search for this author inPubMed Google Scholar
9. Jing Chen
   You can also search for this author inPubMed Google Scholar
10. Yaran Wu
    You can also search for this author inPubMed Google Scholar
11. Lin Guo
    You can also search for this author inPubMed Google Scholar
12. Jieying Zhu
    You can also search for this author inPubMed Google Scholar
13. Xiangjie Zhao
    You can also search for this author inPubMed Google Scholar
14. Tianran Peng
    You can also search for this author inPubMed Google Scholar
15. Yixin Zhang
    You can also search for this author inPubMed Google Scholar
16. Shen Chen
    You can also search for this author inPubMed Google Scholar
17. Xuejia Li
    You can also search for this author inPubMed Google Scholar
18. Dongwei Li
    You can also search for this author inPubMed Google Scholar
19. Tao Wang
    You can also search for this author inPubMed Google Scholar
20. Duanqing Pei
    You can also search for this author inPubMed Google Scholar

Contributions

Jiekai Chen initiated the study, designed and performed the experiments, analyzed the data and wrote the manuscript. H. Liu performed the experiments and analyzed the data. J.L., Jing Chen and L.G. performed reprogramming experiments. J.Q., J.Y. and Y.W. constructed plasmids and performed experiments on histone modification. B.W., T.P., Y.Z. and D.L. performed coimmunoprecipitation experiments. J.Y. performed qPCR analyses and chromatin immunoprecipitation experiments. H. Liang constructed plasmids and analyzed Smad phosphorylation. Y.C. derived iX pre-iPSCs and screened small molecule compounds on pre-iPSCs. J.Y., Jing Chen, J.Z. and X.L. identified the pre-iPSCs and iPSCs. X.Z. performed blastocyst injection. S.C. isolated hepatocytes. T.W. cloned histone demethylases. D.P. conceived and supervised the whole study and wrote the manuscript.

Corresponding author

Correspondence toDuanqing Pei.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Rights and permissions

About this article

Cite this article

Chen, J., Liu, H., Liu, J. et al. H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs.Nat Genet 45, 34–42 (2013). https://doi.org/10.1038/ng.2491

Download citation

• Received: 21 May 2012
• Accepted: 08 November 2012
• Published: 02 December 2012
• Issue Date: January 2013
• DOI: https://doi.org/10.1038/ng.2491